시장조사 보고서 : 세계의 다발성 골수종 치료제 시장예측 2021년-2026년

■ 영문 제목 : Global Multiple Myeloma Therapeutics Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02234 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 97 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 다발성 골수종 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (화학 치료, 방사선, 줄기 세포 이식, 기타)와 용도별 시장규모 (병원, 진료소, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 다발성 골수종 치료제 시장 점유율
- 지역별 다발성 골수종 치료제 시장규모
- 주요지역의 종류별 시장규모 (화학 치료, 방사선, 줄기 세포 이식, 기타)
- 주요지역의 용도별 시장규모 (병원, 진료소, 기타)
- 미주의 다발성 골수종 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 다발성 골수종 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 다발성 골수종 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 다발성 골수종 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 다발성 골수종 치료제 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Janssen Biotech, Inc., Bristol-Myers Squibb, Novartis AG, Bristol-Myers Squibb Company, Millennium Pharmaceuticals, Celgene Corporation, Kesios Therapeutics Limited, Amgene, Inc., Genzyme Corporation, Juno Therapeutics
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Multiple Myeloma Therapeutics will have significant change from previous year. By the most conservative estimates of global Multiple Myeloma Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 26680 million in 2020. Over the next five years the Multiple Myeloma Therapeutics market will register a 11.0% CAGR in terms of revenue, the global market size will reach US$ 40550 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Multiple Myeloma Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Chemotherapy
Radiation
Stem Cell Transplant
Other Supportive Treatments

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Janssen Biotech, Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene, Inc.
Genzyme Corporation
Juno Therapeutics

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Multiple Myeloma Therapeutics Market Size 2016-2026
2.1.2 Multiple Myeloma Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Multiple Myeloma Therapeutics Segment by Type
2.2.1 Chemotherapy
2.2.2 Chemotherapy
2.2.3 Stem Cell Transplant
2.2.4 Other Supportive Treatments
2.3 Multiple Myeloma Therapeutics Market Size by Type
2.3.1 Global Multiple Myeloma Therapeutics Market Size CAGR by Type
2.3.2 Global Multiple Myeloma Therapeutics Market Size Market Share by Type (2016-2021)
2.4 Multiple Myeloma Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Multiple Myeloma Therapeutics Market Size by Application
2.5.1 Global Multiple Myeloma Therapeutics Market Size CAGR by Application
2.5.2 Global Multiple Myeloma Therapeutics Market Size Market Share by Application (2016-2021)

3 Multiple Myeloma Therapeutics Market Size by Players
3.1 Multiple Myeloma Therapeutics Market Size Market Share by Players
3.1.1 Global Multiple Myeloma Therapeutics Revenue by Players (2019-2021E)
3.1.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Players (2019-2021E)
3.2 Global Multiple Myeloma Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Multiple Myeloma Therapeutics by Regions
4.1 Multiple Myeloma Therapeutics Market Size by Regions (2016-2021)
4.2 Americas Multiple Myeloma Therapeutics Market Size Growth (2016-2021)
4.3 APAC Multiple Myeloma Therapeutics Market Size Growth (2016-2021)
4.4 Europe Multiple Myeloma Therapeutics Market Size Growth (2016-2021)
4.5 Middle East & Africa Multiple Myeloma Therapeutics Market Size Growth (2016-2021)

5 Americas
5.1 Americas Multiple Myeloma Therapeutics Market Size by Country (2016-2021)
5.2 Americas Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
5.3 Americas Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Multiple Myeloma Therapeutics Market Size by Region (2016-2021)
6.2 APAC Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
6.3 APAC Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Multiple Myeloma Therapeutics by Country (2016-2021)
7.2 Europe Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
7.3 Europe Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Multiple Myeloma Therapeutics by Region (2016-2021)
8.2 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
8.3 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Multiple Myeloma Therapeutics Market Forecast
10.1 Global Multiple Myeloma Therapeutics Forecast by Regions (2021-2026)
10.1.1 Global Multiple Myeloma Therapeutics Forecast by Regions (2021-2026)
10.1.2 Americas Multiple Myeloma Therapeutics Forecast
10.1.3 APAC Multiple Myeloma Therapeutics Forecast
10.1.4 Europe Multiple Myeloma Therapeutics Forecast
10.1.5 Middle East & Africa Multiple Myeloma Therapeutics Forecast
10.2 Americas Multiple Myeloma Therapeutics Forecast by Countries (2021-2026)
10.2.1 United States Multiple Myeloma Therapeutics Market Forecast
10.2.2 Canada Multiple Myeloma Therapeutics Market Forecast
10.2.3 Mexico Multiple Myeloma Therapeutics Market Forecast
10.2.4 Brazil Multiple Myeloma Therapeutics Market Forecast
10.3 APAC Multiple Myeloma Therapeutics Forecast by Region (2021-2026)
10.3.1 China Multiple Myeloma Therapeutics Market Forecast
10.3.2 Japan Multiple Myeloma Therapeutics Market Forecast
10.3.3 Korea Multiple Myeloma Therapeutics Market Forecast
10.3.4 Southeast Asia Multiple Myeloma Therapeutics Market Forecast
10.3.5 India Multiple Myeloma Therapeutics Market Forecast
10.3.6 Australia Multiple Myeloma Therapeutics Market Forecast
10.4 Europe Multiple Myeloma Therapeutics Forecast by Country (2021-2026)
10.4.1 Germany Multiple Myeloma Therapeutics Market Forecast
10.4.2 France Multiple Myeloma Therapeutics Market Forecast
10.4.3 UK Multiple Myeloma Therapeutics Market Forecast
10.4.4 Italy Multiple Myeloma Therapeutics Market Forecast
10.4.5 Russia Multiple Myeloma Therapeutics Market Forecast
10.5 Middle East & Africa Multiple Myeloma Therapeutics Forecast by Region (2021-2026)
10.5.1 Egypt Multiple Myeloma Therapeutics Market Forecast
10.5.2 South Africa Multiple Myeloma Therapeutics Market Forecast
10.5.3 Israel Multiple Myeloma Therapeutics Market Forecast
10.5.4 Turkey Multiple Myeloma Therapeutics Market Forecast
10.5.5 GCC Countries Multiple Myeloma Therapeutics Market Forecast
10.6 Global Multiple Myeloma Therapeutics Forecast by Type (2021-2026)
10.7 Global Multiple Myeloma Therapeutics Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Janssen Biotech, Inc.
11.1.1 Janssen Biotech, Inc. Company Information
11.1.2 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Product Offered
11.1.3 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Janssen Biotech, Inc. Main Business Overview
11.1.5 Janssen Biotech, Inc. Latest Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Multiple Myeloma Therapeutics Product Offered
11.2.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Bristol-Myers Squibb Main Business Overview
11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Multiple Myeloma Therapeutics Product Offered
11.3.3 Novartis AG Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Novartis AG Main Business Overview
11.3.5 Novartis AG Latest Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Information
11.4.2 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product Offered
11.4.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Bristol-Myers Squibb Company Main Business Overview
11.4.5 Bristol-Myers Squibb Company Latest Developments
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Information
11.5.2 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product Offered
11.5.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Millennium Pharmaceuticals Main Business Overview
11.5.5 Millennium Pharmaceuticals Latest Developments
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Information
11.6.2 Celgene Corporation Multiple Myeloma Therapeutics Product Offered
11.6.3 Celgene Corporation Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Celgene Corporation Main Business Overview
11.6.5 Celgene Corporation Latest Developments
11.7 Kesios Therapeutics Limited
11.7.1 Kesios Therapeutics Limited Company Information
11.7.2 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product Offered
11.7.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Kesios Therapeutics Limited Main Business Overview
11.7.5 Kesios Therapeutics Limited Latest Developments
11.8 Amgene, Inc.
11.8.1 Amgene, Inc. Company Information
11.8.2 Amgene, Inc. Multiple Myeloma Therapeutics Product Offered
11.8.3 Amgene, Inc. Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Amgene, Inc. Main Business Overview
11.8.5 Amgene, Inc. Latest Developments
11.9 Genzyme Corporation
11.9.1 Genzyme Corporation Company Information
11.9.2 Genzyme Corporation Multiple Myeloma Therapeutics Product Offered
11.9.3 Genzyme Corporation Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Genzyme Corporation Main Business Overview
11.9.5 Genzyme Corporation Latest Developments
11.10 Juno Therapeutics
11.10.1 Juno Therapeutics Company Information
11.10.2 Juno Therapeutics Multiple Myeloma Therapeutics Product Offered
11.10.3 Juno Therapeutics Multiple Myeloma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Juno Therapeutics Main Business Overview
11.10.5 Juno Therapeutics Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Multiple Myeloma Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Radiation
Table 4. Major Players of Stem Cell Transplant
Table 5. Major Players of Other Supportive Treatments
Table 6. Multiple Myeloma Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Multiple Myeloma Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Multiple Myeloma Therapeutics Market Size Market Share by Type (2016-2021)
Table 9. Multiple Myeloma Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Multiple Myeloma Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Multiple Myeloma Therapeutics Market Size Market Share by Application (2016-2021)
Table 12. Global Multiple Myeloma Therapeutics Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Multiple Myeloma Therapeutics Revenue Market Share by Players (2019-2021E)
Table 14. Multiple Myeloma Therapeutics Key Players Head office and Products Offered
Table 15. Multiple Myeloma Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Multiple Myeloma Therapeutics Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Multiple Myeloma Therapeutics Market Size Market Share by Regions 2016-2021
Table 20. Americas Multiple Myeloma Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Multiple Myeloma Therapeutics Market Size Market Share by Country (2016-2021)
Table 22. Americas Multiple Myeloma Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Multiple Myeloma Therapeutics Market Size Market Share by Type (2016-2021)
Table 24. Americas Multiple Myeloma Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Multiple Myeloma Therapeutics Market Size Market Share by Application (2016-2021)
Table 26. APAC Multiple Myeloma Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Multiple Myeloma Therapeutics Market Size Market Share by Region (2016-2021)
Table 28. APAC Multiple Myeloma Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Multiple Myeloma Therapeutics Market Size Market Share by Type (2016-2021)
Table 30. APAC Multiple Myeloma Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Multiple Myeloma Therapeutics Market Size Market Share by Application (2016-2021)
Table 32. Europe Multiple Myeloma Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Multiple Myeloma Therapeutics Market Size Market Share by Country (2016-2021)
Table 34. Europe Multiple Myeloma Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Multiple Myeloma Therapeutics Market Size Market Share by Type (2016-2021)
Table 36. Europe Multiple Myeloma Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Multiple Myeloma Therapeutics Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Multiple Myeloma Therapeutics Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Multiple Myeloma Therapeutics Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Multiple Myeloma Therapeutics Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Multiple Myeloma Therapeutics
Table 45. Key Application and Potential Industries of Multiple Myeloma Therapeutics
Table 46. Key Challenges of Multiple Myeloma Therapeutics
Table 47. Key Trends of Multiple Myeloma Therapeutics
Table 48. Global Multiple Myeloma Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Multiple Myeloma Therapeutics Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Multiple Myeloma Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Multiple Myeloma Therapeutics Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Multiple Myeloma Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Multiple Myeloma Therapeutics Market Size Market Share Forecast by Application (2021-2026)
Table 54. Janssen Biotech, Inc. Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 55. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Product Offered
Table 56. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Janssen Biotech, Inc. Main Business
Table 58. Janssen Biotech, Inc. Latest Developments
Table 59. Bristol-Myers Squibb Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 60. Bristol-Myers Squibb Multiple Myeloma Therapeutics Product Offered
Table 61. Bristol-Myers Squibb Main Business
Table 62. Bristol-Myers Squibb Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Bristol-Myers Squibb Latest Developments
Table 64. Novartis AG Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 65. Novartis AG Multiple Myeloma Therapeutics Product Offered
Table 66. Novartis AG Main Business
Table 67. Novartis AG Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Novartis AG Latest Developments
Table 69. Bristol-Myers Squibb Company Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 70. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product Offered
Table 71. Bristol-Myers Squibb Company Main Business
Table 72. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. Bristol-Myers Squibb Company Latest Developments
Table 74. Millennium Pharmaceuticals Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 75. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product Offered
Table 76. Millennium Pharmaceuticals Main Business
Table 77. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Millennium Pharmaceuticals Latest Developments
Table 79. Celgene Corporation Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 80. Celgene Corporation Multiple Myeloma Therapeutics Product Offered
Table 81. Celgene Corporation Main Business
Table 82. Celgene Corporation Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Celgene Corporation Latest Developments
Table 84. Kesios Therapeutics Limited Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 85. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product Offered
Table 86. Kesios Therapeutics Limited Main Business
Table 87. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Kesios Therapeutics Limited Latest Developments
Table 89. Amgene, Inc. Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 90. Amgene, Inc. Multiple Myeloma Therapeutics Product Offered
Table 91. Amgene, Inc. Main Business
Table 92. Amgene, Inc. Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. Amgene, Inc. Latest Developments
Table 94. Genzyme Corporation Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 95. Genzyme Corporation Multiple Myeloma Therapeutics Product Offered
Table 96. Genzyme Corporation Main Business
Table 97. Genzyme Corporation Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Genzyme Corporation Latest Developments
Table 99. Juno Therapeutics Details, Company Type, Multiple Myeloma Therapeutics Area Served and Its Competitors
Table 100. Juno Therapeutics Multiple Myeloma Therapeutics Product Offered
Table 101. Juno Therapeutics Main Business
Table 102. Juno Therapeutics Multiple Myeloma Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. Juno Therapeutics Latest Developments
List of Figures
Figure 1. Multiple Myeloma Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Multiple Myeloma Therapeutics Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Multiple Myeloma Therapeutics Market Size Market Share by Type in 2020
Figure 7. Multiple Myeloma Therapeutics in Hospitals
Figure 8. Global Multiple Myeloma Therapeutics Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Multiple Myeloma Therapeutics in Clinics
Figure 10. Global Multiple Myeloma Therapeutics Market: Clinics (2016-2021) & ($ Millions)
Figure 11. Multiple Myeloma Therapeutics in Others
Figure 12. Global Multiple Myeloma Therapeutics Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Multiple Myeloma Therapeutics Market Size Market Share by Application in 2020
Figure 14. Global Multiple Myeloma Therapeutics Revenue Market Share by Player in 2020
Figure 15. Global Multiple Myeloma Therapeutics Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Multiple Myeloma Therapeutics Market Size 2016-2021 ($ Millions)
Figure 17. APAC Multiple Myeloma Therapeutics Market Size 2016-2021 ($ Millions)
Figure 18. Europe Multiple Myeloma Therapeutics Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Multiple Myeloma Therapeutics Market Size 2016-2021 ($ Millions)
Figure 20. Americas Multiple Myeloma Therapeutics Market Size Market Share by Country in 2020
Figure 21. Americas Multiple Myeloma Therapeutics Market Size Market Share by Type in 2020
Figure 22. Americas Multiple Myeloma Therapeutics Market Size Market Share by Application in 2020
Figure 23. United States Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Multiple Myeloma Therapeutics Market Size Market Share by Regions in 2020
Figure 27. APAC Multiple Myeloma Therapeutics Market Size Market Share by Type in 2020
Figure 28. APAC Multiple Myeloma Therapeutics Market Size Market Share by Application in 2020
Figure 29. China Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Multiple Myeloma Therapeutics Market Size Market Share by Country in 2020
Figure 36. Europe Multiple Myeloma Therapeutics Market Size Market Share by Type in 2020
Figure 37. Europe Multiple Myeloma Therapeutics Market Size Market Share by Application in 2020
Figure 38. Germany Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Multiple Myeloma Therapeutics Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Multiple Myeloma Therapeutics Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Multiple Myeloma Therapeutics Market Size Market Share by Application in 2020
Figure 46. Egypt Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Multiple Myeloma Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 52. APAC Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 53. Europe Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 55. United States Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 56. Canada Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 59. China Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 60. Japan Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 61. Korea Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 63. India Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 64. Australia Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 65. Germany Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 66. France Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 67. UK Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 68. Italy Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 69. Russia Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 70. Spain Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 73. Israel Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Multiple Myeloma Therapeutics Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 다발성 골수종 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02234) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 다발성 골수종 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 난소암 치료제 시장예측 2021년-2026년
LPI-2201K02256 / LP Information / 2021년 12월 / 본 조사보고서는 난소암 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Ovarian Cancer Therapeutics will have significant change from previous year. By the most conservative estimates of global Ovarian Cancer Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1725.9 million in...

세계의 HIV 치료제 시장예측 2021년-2026년
LPI-2201K00128 / LP Information / 2021년 12월 / 본 조사보고서는 HIV 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of HIV Therapeutics will have significant change from previous year. By the most conservative estimates of global HIV Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 혈우병 A 및 B 치료제 시장예측 2021년-2026년
LPI-2201K00221 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Hemophillia A and B Therapeutics Materials will have significant change from previous year. By the most conservative estimates of global Hemophillia A and B Therapeutics Materials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...

세계의 혈우병 치료제 시장예측 2021년-2026년
LPI-2201K00121 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hemophilia Therapeutics will have significant change from previous year. By the most conservative estimates of global Hemophilia Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 9275.3 million in 2020. Over...

세계의 표적 단백질 분해 치료제 시장예측 2021년-2026년
LPI-2201K02312 / LP Information / 2021년 12월 / 본 조사보고서는 표적 단백질 분해 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Targeted-protein Degradation Therapeutics will have significant change from previous year. By the most conservative estimates of global Targeted-protein Degradation Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 올리고뉴클레오티드 치료제 시장예측 2021년-2026년
LPI-2201K02248 / LP Information / 2021년 12월 / 본 조사보고서는 올리고뉴클레오티드 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Oligonucleotide Therapeutics will have significant change from previous year. By the most conservative estimates of global Oligonucleotide Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3083.2 million in 2020. Over...

세계의 소양증 치료제 시장예측 2021년-2026년
LPI-2201K02285 / LP Information / 2021년 12월 / 본 조사보고서는 소양증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pruritus Therapeutics will have significant change from previous year. By the most conservative estimates of global Pruritus Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12760 million in 2020. Over...